
Japanese trading house Itochu on Wednesday announced a 581 billion yen ($5.4 billion) tender offer for the rest of convenience store FamilyMart, reports Reuters.
Itochu, which owns 50.1% of the FamilyMart chain, will offer 2,300 yen per share, a 31% premium to Wednesday’s closing price. The offer runs from Thursday through Aug. 24 and Itochu expects to delist FamilyMart if the bid is successful.
FamilyMart, Japan’s second-biggest convenience store chain with more than 16,000 outlets across the country, said it supported the offer.
Itochu said it wanted full control of FamilyMart in part to speed up decision-making at the chain, which competes with 7-Eleven, part of retail giant Seven & i Holdings, and Lawson), owned by trading house Mitsubishi.
The stores, ubiquitous in Japan and offering everything from “bento” pre-made meals to socks and underwear, have faced slower growth in recent years.
In addition to a shrinking population and sluggish consumer spending, the industry is also grappling with a shortage of workers and tough competition from drugstores, which started selling food following deregulation.
Full ownership would also allow Itochu to shift further away from the struggling energy and mining businesses to focus on the consumer sector, which offers more stability as well as a chance to leverage its other food operations. Itochu acquired Dole Food Company’s Asian fresh produce and worldwide packaged food business in 2013.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas